UAMY Stock Heads Toward Biggest Single Day Loss In Over 9 Months – But H.C. Wainwright Still Has A ‘Buy’ Rating

H.C. Wainwright retained its ‘Buy’ rating on the stock, citing balance-sheet improvements and growth potential in its zeolite business.
Trending stocks chart. (Image Courtesy: Getty Images)
Trending stocks chart. (Image Courtesy: Getty Images)
Profile Image
Arnab Paul·Stocktwits
Published Aug 12, 2026   |   10:31 AM EDT
Share
·
Add us onAdd us on Google
Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...
  • United States Antimony reported Q2 revenue of $7.9 million, well below analysts’ estimate of $21.7 million, according to Fiscal.ai.
  • The company slashed its full-year 2026 revenue outlook to $60 million to $75 million from its previous target of $125 million.
  • Q2 zeolite revenues more than doubled to $1.9 million.

Advertisement|Remove ads.

Shares of United States Antimony (UAMY) crashed nearly 20% on Wednesday following its second-quarter results, but H.C. Wainwright retained its ‘Buy’ rating on the stock, citing balance-sheet improvements and growth potential in its zeolite business.

The brokerage cut the stock’s price target to $9.25 from $11.75, according to TheFly. Still, it represents a potential upside of more than 60% from current levels.

Read Next
Loading...
Loading...

UAMY stock is on track to clock its biggest single-day slide since October 2025.

Advertisement|Remove ads.

Antimony Prices Hurt Q2 Revenue

On Tuesday, United States Antimony reported second-quarter (Q2) revenue of $7.9 million, down 25% from a year earlier and well below analysts’ estimate of $21.7 million, according to Fiscal.ai.

Antimony sales volume increased 26% to 428,425 pounds, but the average selling price fell to $13.70 per pound from $28.32 last year. This led the company to slash its full-year 2026 revenue outlook to between $60 million and $75 million from its previous target of $125 million.

H.C. Wainwright said the company’s reduced outlook appears more realistic given current antimony prices and the timing of its production ramp, according to a report by Tipranks. It also highlighted the expansion of the Thompson Falls smelter in Montana and the start of shipments to the Defense Logistics Agency as important steps toward scaling the antimony business.

Advertisement|Remove ads.

The stock has a consensus 12-month price target of $12.56, according to Koyfin. All four analysts covering the stock have rated it a ‘Buy.’

Zeolite Offers A Bright Spot

Zeolite mineral revenues more than doubled to $1.9 million, while sales volume rose 114% to 6,609 tons. Growth was driven by stronger demand from the cattle industry and wider distribution across traditional industrial markets.

United States Antimony’s working capital doubled to $70 million at the end of June from $35 million at the end of March, mainly due to equity issuances. Cash and equivalents rose to $41.4 million from $30.5 million at the end of 2025, while investments in U.S. Treasury securities edged up to $20.7 million from $20.4 million.

Advertisement|Remove ads.

Retail Says UAMY Is Way Oversold

Retail sentiment surrounding UAMY on Stocktwits remained ‘bullish’ over the past 24 hours, amid a 167% increase in message volumes.

One bullish user expects the next four quarters to be “explosive.”

Advertisement|Remove ads.

Another said the stock is way oversold.

The stock is down around 12% so far this year.

Advertisement|Remove ads.

Also read: Liquidia CEO Roger Jeffs Says Demand For Inhaled Lung Disease Drug Is Growing Amid Q2 Revenue Beat

For updates and corrections, email newsroom[at]stocktwits[dot]com.

Comments
Share your thoughts...

Comments posted here will also appear on symbol pages.

Follow on Google News
Read about our editorial guidelines and ethics policy

Advertisement|Remove ads.